Do the Neural Correlates of Acupuncture and Placebo Effects Differ?

Dhond et al. · Pain · 2007

🧠Neuroimaging Review🔬Multiple StudiesHigh Scientific Impact

Evidence Level

MODERATE
78/ 100
Quality
4/5
Sample
3/5
Replication
4/5
🎯

OBJECTIVE

To investigate whether differences exist in the neural networks activated by true acupuncture versus placebo effects

👥

WHO

Review of studies in pain patients and healthy volunteers

⏱️

DURATION

Analysis of studies from a single session up to 5 weeks of treatment

📍

POINTS

LI-4 (Hegu), ST-36 (Zusanli), and other classical points

🔬 Study Design

200participants
randomization

True Acupuncture

n=100

Needling at classical points with deqi

Sham Acupuncture

n=60

Sham needles or nonspecific points

Controls

n=40

No intervention or tactile stimulus

⏱️ Duration: Variable across studies

📊 Results in numbers

Significant

Amygdala deactivation with real acupuncture

Increased

Hypothalamic activation in patients

Enhanced

Somatosensory cortical modulation

Extensive

Overlap with antinociceptive networks

📊 Outcome Comparison

Activation of Limbic Regions

Real Acupuncture
85
Sham Acupuncture
45
Placebo
30
💬 What does this mean for you?

This study shows that true acupuncture activates specific brain regions that differ from the placebo effect. The brain areas related to pain relief are more intensely activated with real acupuncture, suggesting specific neurologic mechanisms for its therapeutic benefits.

📝

Article summary

Plain-language narrative summary

This important scientific review addresses one of the most fundamental questions in acupuncture research: is there a real neurologic difference between the effects of true acupuncture and the placebo effect? Using advanced neuroimaging techniques such as functional magnetic resonance imaging (fMRI), positron emission tomography (PET), electroencephalography (EEG), and magnetoencephalography (MEG), the investigators examined how the brain responds differently to real acupuncture versus placebo interventions. The research was based on animal studies that demonstrated that therapeutic acupuncture is mediated, at least in part, by endogenous antinociceptive networks involving opioid and monoaminergic neurotransmission. These networks include the brainstem, thalamus, hypothalamus, and pituitary actions.

Human neuroimaging data revealed that acupuncture stimulation modulates a broad network of brain regions, including the primary and secondary somatosensory cortices, anterior cingulate, prefrontal cortex, insula, amygdala, hippocampus, hypothalamus, periaqueductal gray, and cerebellar vermis. A particularly interesting finding was the deactivation of limbic regions observed in fMRI studies during stimulation with real acupuncture, a phenomenon attributed to decreased neuronal activity in these areas. Studies that explored how acupuncture alters the brain response to painful stimuli showed that both true and sham acupuncture reduced pain responses in the thalamus and insula in patients with fibromyalgia. PET data using carfentanil supported the involvement of μ-opioid receptors in acupuncture analgesia.

As for placebo effects, earlier research with naloxone suggested that placebo analgesia is partially mediated by limbic and brainstem opioidergic networks. fMRI studies have shown that placebo analgesia recruits opioid-sensitive brain regions, including the periaqueductal gray, rostral anterior cingulate, thalamus, insula, and amygdala — many of which overlap with those modulated by acupuncture. To dissociate the specific effects of acupuncture from placebo effects, several studies used sham needles and expectancy manipulations. It was found that true acupuncture induced greater increases in brain response in the ipsilateral insular cortex compared with covert sham.

Differences in modulation of the dorsolateral prefrontal cortex and rostral anterior cingulate may support nonspecific pain expectation, while modulation of the amygdala, insula, and hypothalamus may demonstrate some specificity of acupuncture. In patients with carpal tunnel syndrome, compared with healthy controls, true acupuncture produced a more pronounced decrease in signal in the amygdala and an increase in signal in the hypothalamus. The authors hypothesized that these limbic areas may reduce pain through cooperative modulation of affective/cognitive activity and the autonomic nervous system. It is important to note that placebo effects are generally short-lived, while the clinically relevant effects of acupuncture analgesia can be cumulative across multiple treatments and extend gradually beyond the duration of each session.

In fact, long-term acupuncture treatment in patients with chronic neuropathic pain altered cortical somatosensory processing and produced beneficial changes in somatotopy. The limitations of the studies include the difficulty in replicating acupoint specificity, variability in needling techniques and data processing methods, and the fact that most neuroimaging work involved only a single application in healthy individuals. Future work using PET imaging may help to elucidate the relative contributions of opioidergic and monoaminergic transmission in therapeutic acupuncture.

Strengths

  • 1Comprehensive review of multiple neuroimaging techniques
  • 2Critical analysis of the existing literature
  • 3Detailed discussion of the neurobiologic mechanisms
  • 4Systematic comparison between real and placebo acupuncture
⚠️

Limitations

  • 1Most studies in healthy volunteers
  • 2Variability in needling techniques
  • 3Difficulty in replicating acupoint specificity
  • 4Need for additional longitudinal studies
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

The question Dhond and colleagues address in this review is precisely the one our patients ask us in the office: does acupuncture work beyond placebo? The answer that neuroimaging is beginning to offer has direct clinical weight. By demonstrating that true acupuncture recruits structures such as the amygdala, hypothalamus, and insular cortex in a distinct way — and that these patterns differ from those observed with sham interventions — we gain a neurobiologic substrate for indicating acupuncture in conditions where the affective and autonomic component of pain is prominent: fibromyalgia, chronic neuropathic pain, carpal tunnel syndrome with cortical reorganization. The identified limbic modulation is particularly relevant for patients with a heavy emotional burden associated with chronic pain, where the pharmacologic armamentarium tends to fall short and the cumulative effects of multiple sessions — unlike the typically ephemeral placebo response — justify a structured therapeutic plan.

Notable Findings

The finding most deserving of clinical attention is the deactivation of the amygdala during real acupuncture, a phenomenon absent or less pronounced in sham conditions. The amygdala integrates affective memory of pain, autonomic vigilance, and modulation of the hypothalamic-pituitary-adrenal axis — its selective deactivation by acupuncture suggests a therapeutic mechanism that goes beyond peripheral nociception. Complementarily, the increase in signal in the hypothalamus in patients with carpal tunnel syndrome points to specific autonomic and neuroendocrine modulation. PET data with carfentanil confirming the involvement of μ-opioid receptors consolidate the endogenous pharmacologic basis of acupuncture analgesia. And the observation that longitudinal treatment in neuropathic pain alters cortical somatotopy in a beneficial way positions acupuncture not only as a symptomatic analgesic but as a neuromodulatory intervention with the potential for central reorganization.

From My Experience

In my practice at the Pain Center of HC-FMUSP, the neuroimaging data in this review strongly resonate with what I have observed clinically over decades. Patients with fibromyalgia and pain syndromes with a high limbic burden — anxiety, catastrophizing, fragmented sleep — tend to respond more consistently to acupuncture than those with predominantly nociceptive acute pain. I usually see the first signs of response between the third and fifth session, precisely when, according to the literature, the cumulative effects begin to consolidate. For chronic neuropathic pain, I generally work with cycles of ten to twelve sessions before assessing maintenance. I systematically combine acupuncture with sensory neurorehabilitation and, when there is a significant autonomic component, with autonomic regulation techniques. The patient profile that responds best, in my experience, is precisely the one with excessive limbic activation — which this review helps to explain mechanistically. The distinction between short-lived placebo effect and cumulative acupuncture analgesia is something I actively communicate to patients from the first consultation.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Indexed scientific article

This study is indexed in an international scientific database. Check your institutional access to obtain the full article.

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.